Capricor Therapeutics (CAPR) Financials

$8.37

$0.07 (0.84%)

As on 11-Sep-2026 16:20EDT

Market cap

$547 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	22.27	25.18	2.55	0.24
Cost of Revenue	20.36	--	49.97	36.45	21.82	0.25
Gross Profit	-20.36	--	-27.70	-11.27	-19.27	0.24
Operating Expenses	114.80	108.14	14.87	12.81	10.43	21.18
Operating Profit (EBIT)	-135.16	-108.14	-42.56	-24.08	-29.70	-20.94
Other Income	--	--	--	--	0.68	0.92
Profit before Tax	-129.41	-105.04	-40.47	-22.29	-29.02	-20.02
Provision for Tax	0.00	--	--	0.00	0.00	-0.61
Profit after Tax (Net Income)	-129.42	-105.04	-40.47	-22.29	-29.02	-20.02
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-29.02	-20.02

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	246.22	305.79	145.46	22.60	11.79	31.37
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	89.56	14.32	3.99	4.86	14.72	5.83
Current Liabilities	32.96	35.84	21.03	31.27	23.59	4.13
Total Liabilities	401.70	355.95	170.48	58.73	50.09	41.33

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	126.61	33.01	7.10	7.88	7.21	4.89
Current Assets	242.13	322.94	163.39	50.86	42.89	36.44
Total Assets	401.70	355.95	170.48	58.73	50.09	41.33
Total Debt*	91.05	17.94	4.83	5.61	4.06	3.79
Net Current Assets	209.17	287.10	142.36	19.59	19.30	32.30

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-69.81	-40.00	-25.60	4.92	-16.81
Cash Flow from Investing Activities	--	97.48	-116.18	5.11	-35.07	-1.20
Cash from Financing Activities	--	248.89	152.77	25.58	4.87	20.23
Net Cash Inflow / Outflow	--	--	--	--	-25.28	2.22

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.45	-2.15	-1.15	-0.83	-1.15	-0.83
Cash EPS ($)	--	-2.11	-1.11	-0.80	-1.13	-0.82
Adjusted Book Value ($)	--	6.26	4.13	0.84	0.47	1.30
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.43	-1.14	-0.96	0.20	-0.70
Free Cash Flow per Share ($)	--	-1.49	-1.18	-1.03	0.06	-0.75

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-44.32	-45.34	-101.17	-113.79	-59.72
ROE (%)	-46.89	-46.56	-48.16	-129.63	-134.49	-67.23
ROA (%)	-45.92	-39.91	-35.31	-40.96	-63.48	-52.73
EBIT Margin (%)	--	--	-181.71	-88.52	-1,137.37	-8,175.86
Net Margin (%)	--	--	-181.71	-88.52	-898.63	-1,724.86
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-1.00	-0.12	8.87	9.42	-0.21
EBIT Growth (%)	-80.59	-152.05	-81.57	23.20	-44.93	-46.26
Net Profit Growth (%)	-84.94	-159.58	-81.57	23.20	-44.93	-46.61
EPS Growth (%)	-45.54	-0.87	-0.38	0.28	-0.39	-0.24
Book Value Growth (%)	85.08	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-13.42	-12.01	-5.88	-3.35	-3.53
Price / Book Value	2.36	4.61	3.34	5.79	8.24	2.26
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.73	-11.08	-8.69	-4.57	-2.10	-2.01
Close Price ($)	24.08	28.86	13.80	4.89	3.86	2.93
High Price ($)	40.37	40.37	23.40	8.22	6.58	8.40
Low Price ($)	4.30	4.30	3.52	2.68	2.56	2.75
Market Cap ($ Cr)	546.51	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.06	0.03	0.25	0.34	0.12
Short term debt to equity ratio	0.01	0.01	0.01	0.03	0.06	0.01
Current Ratio	7.35	9.01	7.77	1.63	1.82	8.82
Quick Ratio	7.35	--	--	1.63	1.82	8.82
Interest Coverage	-41.49	-33.49	--	--	-17.09	-19.29

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	46.56	41.19	21.46	159.96
Asset Turnover	--	--	0.19	0.46	0.06	0.01
Receivable days	--	--	170.08	79.20	67.23	333.90
Inventory Days	--	--	0.00	0.00	0.00	-41.62
Payable days	--	--	34.81	55.49	71.57	4,787.07
Cash Conversion Cycle	--	--	135.27	23.71	-4.34	-4,494.80

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.